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Lead failure rates of implantable cardioverter-deﬁbrillators
(ICDs) vary depending on design and composition, and can
be as high as 40% a few years post implant.1 The Sprint
Fidelis lead (Medtronic, Minneapolis, MN) was recalled in
2007 because it is prone to fracture, particularly to its pace-
sense conductor, which predisposes patients to inappropriate
shocks;2 its yearly failure rate is estimated at 3.75%, with
acceleration in failure rates after ﬁrst implant year.2 Manage-
ment of patients with Fidelis leads is based on lead status
and patient proﬁle and can include noninvasive monitoring
of a functional lead, abandoning the old and adding a new
ICD or a pace-sense lead, and complete extraction and
reimplant of a new lead. We present a case where an
abandoned Fidelis lead damaged its neighboring lead from
lead-on-lead friction and discuss our proposed management
of such cases.Figure 1 A: Posteroanterior chest radiograph view depicting intact insulation of
radiograph zoomed-in view of the described leads (white arrow: site of lead-on-le
KEYWORDS Lead extraction; Lead-on-lead interaction; Lead insulation damage
(Heart Rhythm Case Reports 2016;2:157–158)
Address reprint requests and correspondence: Dr Laurence M. Epstein,
Division of Cardiovascular Medicine, Brigham and Women’s Hospital, 75
Francis St, Boston, MA 02118. E-mail address: lmepstein@partners.org.
2214-0271 B 2016 Heart Rhythm Society. Published by Elsevier Inc. This is an o
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Case report
A 48-year-old man with nonischemic dilated cardiomyop-
athy had an ICD implant for secondary prevention, which
included a dual-coil Sprint Fidelis (6949) lead. In 2010, the
Fidelis lead was capped and abandoned owing to fracture
and a new St Jude Medical 7121 Durata lead (St Jude
Medical, St Paul, MN) was added. The patient sought
medical attention after his St Jude Medical Fortify ICD
alarm was triggered owing to reduced lead impedance at 180
ohms; impedance trend was gradually decreasing but never
led to oversensing or inappropriate therapies. Radiographs
did not show any clear insulation breach; however, they did
demonstrate the new ICD lead crossing the old one
(Figure 1). Given that a reliably functioning ICD lead was
necessary for this patient, discussions regarding treatment
options culminated in a complete system extraction and
reimplant strategy. Successful extraction of both ICD leadsboth the abandoned Sprint Fidelis and added Durata leads. B: Lateral chest
ad interaction; white arrowhead: newly implanted Durata lead).was performed as previously described using an LLD and 16
F laser sheath (Spectranetics, Colorado Springs, CO). The
site of the Durata lead insulation breach was proximal to the
distal deﬁbrillation coil where it crossed the right ventricular
coil of the abandoned Sprint Fidelis lead (Figure 2). The
mechanism of insulation breach was very likely lead-on-leadpen access article under the CC BY-NC-ND license
http://dx.doi.org/10.1016/j.hrcr.2015.12.007
Figure 2 Insulation breach in the extracted St Jude Medical Durata lead
near the distal deﬁbrillation coil.
KEY TEACHING POINTS
 The management of failed cardiac electronic device
leads continues to be clinically challenging. The
chosen treatment option should be individualized
based on the patient’s clinical status and
physician’s surgical experience.
 Lead-on-lead interaction and insulation damage is
a real concern when a new lead is implanted
adjacent to an abandoned one, and can be avoided
with lead extraction when clinically indicated.
 Lead extraction procedures after careful clinical
evaluation are relatively safe when performed in an
experienced center.
Heart Rhythm Case Reports, Vol 2, No 2, March 2016158friction between the 2 leads at the atrioventricular junction
where they crossed the tricuspid valve (Figure 1).
Discussion
This case illustrates one of the many potential pitfalls of
abandoning a failed ICD lead. Lead-on-lead interaction and
insulation abrasion from friction with another have been
reported in St Jude Medical Riata and Durata ICD leads.3
To eliminate the risk of similar lead-on-lead insulation
abrasion, it is thus ideal to have a failed lead completely
extracted prior to adding a new one. The major concern with
this approach is the risk of complications that can be
associated with extraction. Fortunately, with improved
techniques and operator experience over time, lead extrac-
tions can now be performed safely at high-volume centers
with negligible rates of major procedural complications or
deaths.4 Although this case involved a recalled Fidelis lead,
the recalled Riata lead may pose an even higher risk of
abandonment. The extrusion of cables has been associated
not only with lead–lead interaction, but also with thrombus
formation and cable migration. In addition to lead–lead
interactions, lead abandonment has been associated with an
increased risk of infection, issues with venous occlusion,
future difﬁcultly of extraction, and the prohibition of future
magnetic resonance imaging scanning.5 As always, treat-
ment decisions should be made on a case-by-case, individual
basis. However, if extraction can be offered with a highsuccess and low complication rate, it should be considered
for patients with failed ICD leads and with a reasonable life
expectancy.
Conclusion
The management of failed cardiac electronic device leads
continues to be clinically challenging. Physicians are often
confronted with the option of abandoning or extracting failed
leads prior to adding a novel one. The chosen treatment
option should be individualized based on the patient’s
clinical status and physician’s surgical experience. Lead-
on-lead interaction and insulation damage is a real concern
when a new lead is implanted adjacent to an abandoned one,
and can be avoided with lead extraction when clinically
indicated.
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